Economic evaluation of smoking cessation in Ontario's regional cancer programs

Abstract Quitting smoking after a diagnosis of cancer results in greater response to treatment and decreased risk of disease recurrence and second primary cancers. The objective of this study was to evaluate the potential cost‐effectiveness of two smoking cessation approaches: the current basic smok...

Full description

Bibliographic Details
Main Authors: Sandjar Djalalov, Lisa Masucci, Wanrudee Isaranuwatchai, William Evans, Alice Peter, Rebecca Truscott, Erin Cameron, Nicole Mittmann, Linda Rabeneck, Kelvin Chan, Jeffrey S. Hoch
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1495
id doaj-81c7bfa271364e5fb0565604e3af02ad
record_format Article
spelling doaj-81c7bfa271364e5fb0565604e3af02ad2020-11-25T03:08:28ZengWileyCancer Medicine2045-76342018-09-01794765477210.1002/cam4.1495Economic evaluation of smoking cessation in Ontario's regional cancer programsSandjar Djalalov0Lisa Masucci1Wanrudee Isaranuwatchai2William Evans3Alice Peter4Rebecca Truscott5Erin Cameron6Nicole Mittmann7Linda Rabeneck8Kelvin Chan9Jeffrey S. Hoch10Health Quality Ontario Toronto Ontario CanadaSt. Michael's Hospital Toronto Ontario CanadaSt. Michael's Hospital Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaCancer Care Ontario Toronto Ontario CanadaSt. Michael's Hospital Toronto Ontario CanadaAbstract Quitting smoking after a diagnosis of cancer results in greater response to treatment and decreased risk of disease recurrence and second primary cancers. The objective of this study was to evaluate the potential cost‐effectiveness of two smoking cessation approaches: the current basic smoking cessation program consisting of screening for tobacco use, advice, and referral; and a best practice smoking cessation program that includes the current basic program with the addition of pharmacological therapy, counseling, and follow‐up. A Markov model was constructed that followed 65‐year‐old smokers with cancer over a lifetime horizon. Transition probabilities and mortality estimates were obtained from the published literature. Costs were obtained from standard costing sources in Ontario and reports. Probabilistic and deterministic sensitivity analyses were conducted to address parameter uncertainties. For smokers with cancer, the best practice smoking cessation program was more effective and more costly than the basic smoking cessation program. The incremental cost‐effectiveness ratio of the best practice smoking cessation program compared to the basic smoking cessation program was $3367 per QALY gained and $5050 per LY gained for males, and $2050 per QALY gained and $4100 per LY gained for females. Results were most sensitive to the hazard ratio of mortality for former and current smokers, the probability of quitting smoking through participation in the program and smoking‐attributable costs. The study results suggested that a best practice smoking cessation program could be a cost‐effective option. These findings can support and guide implementation of smoking cessation programs.https://doi.org/10.1002/cam4.1495Cost‐effectivenessoncologysmoking cessation
collection DOAJ
language English
format Article
sources DOAJ
author Sandjar Djalalov
Lisa Masucci
Wanrudee Isaranuwatchai
William Evans
Alice Peter
Rebecca Truscott
Erin Cameron
Nicole Mittmann
Linda Rabeneck
Kelvin Chan
Jeffrey S. Hoch
spellingShingle Sandjar Djalalov
Lisa Masucci
Wanrudee Isaranuwatchai
William Evans
Alice Peter
Rebecca Truscott
Erin Cameron
Nicole Mittmann
Linda Rabeneck
Kelvin Chan
Jeffrey S. Hoch
Economic evaluation of smoking cessation in Ontario's regional cancer programs
Cancer Medicine
Cost‐effectiveness
oncology
smoking cessation
author_facet Sandjar Djalalov
Lisa Masucci
Wanrudee Isaranuwatchai
William Evans
Alice Peter
Rebecca Truscott
Erin Cameron
Nicole Mittmann
Linda Rabeneck
Kelvin Chan
Jeffrey S. Hoch
author_sort Sandjar Djalalov
title Economic evaluation of smoking cessation in Ontario's regional cancer programs
title_short Economic evaluation of smoking cessation in Ontario's regional cancer programs
title_full Economic evaluation of smoking cessation in Ontario's regional cancer programs
title_fullStr Economic evaluation of smoking cessation in Ontario's regional cancer programs
title_full_unstemmed Economic evaluation of smoking cessation in Ontario's regional cancer programs
title_sort economic evaluation of smoking cessation in ontario's regional cancer programs
publisher Wiley
series Cancer Medicine
issn 2045-7634
publishDate 2018-09-01
description Abstract Quitting smoking after a diagnosis of cancer results in greater response to treatment and decreased risk of disease recurrence and second primary cancers. The objective of this study was to evaluate the potential cost‐effectiveness of two smoking cessation approaches: the current basic smoking cessation program consisting of screening for tobacco use, advice, and referral; and a best practice smoking cessation program that includes the current basic program with the addition of pharmacological therapy, counseling, and follow‐up. A Markov model was constructed that followed 65‐year‐old smokers with cancer over a lifetime horizon. Transition probabilities and mortality estimates were obtained from the published literature. Costs were obtained from standard costing sources in Ontario and reports. Probabilistic and deterministic sensitivity analyses were conducted to address parameter uncertainties. For smokers with cancer, the best practice smoking cessation program was more effective and more costly than the basic smoking cessation program. The incremental cost‐effectiveness ratio of the best practice smoking cessation program compared to the basic smoking cessation program was $3367 per QALY gained and $5050 per LY gained for males, and $2050 per QALY gained and $4100 per LY gained for females. Results were most sensitive to the hazard ratio of mortality for former and current smokers, the probability of quitting smoking through participation in the program and smoking‐attributable costs. The study results suggested that a best practice smoking cessation program could be a cost‐effective option. These findings can support and guide implementation of smoking cessation programs.
topic Cost‐effectiveness
oncology
smoking cessation
url https://doi.org/10.1002/cam4.1495
work_keys_str_mv AT sandjardjalalov economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT lisamasucci economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT wanrudeeisaranuwatchai economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT williamevans economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT alicepeter economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT rebeccatruscott economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT erincameron economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT nicolemittmann economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT lindarabeneck economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT kelvinchan economicevaluationofsmokingcessationinontariosregionalcancerprograms
AT jeffreyshoch economicevaluationofsmokingcessationinontariosregionalcancerprograms
_version_ 1724666200096505856